McKesson acquires Precision Medicine from Blackstone

{
  "signal_id": "a947df6d-0baa-2653-d4f4-bb7088c080ef",
  "signal_type": "news",
  "signal_subtype": "sells_assets_to",
  "detected_at": "2026-09-09T10:00:00+00:00",
  "company": {
    "name": "Blackstone",
    "domain": "blackstone.com"
  },
  "data": {
    "url": "https://news.outsourceaccelerator.com/mckesson-precision-medicine/",
    "title": "McKesson acquires Precision Medicine from Blackstone - Outsource Accelerator",
    "assets": "Precision Medicine Group",
    "excerpt": "TEXAS and MARYLAND, UNITED STATES - McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group from Blackstone for approximately $2.25 billion. The purchase adds biomarker intelligence, laboratory services, a global contract research organization, market access consulting, and drug commercialization support to McKesson’s oncology and specialty care portfolio. Closing is subject to customary regulatory clearances. According to a report from Lawrence Evans, McKesson said the acquisition of Precision Medicine Group aligns with its strategy of concentrating capital in oncology and specialty care. The company’s Oncology and Multispecialty segment posted $14.2 billion in revenue in fiscal first-quarter 2026, a 33% year-over-year increase, and McKesson has committed to this segment as its primary growth axis. The deal gives McKesson an owned global contract research organization (CRO), a biomarker intelligence platform, and laboratory analysis capabilities: knowledge process outsourcing (KPO) functions the company had previously accessed through external partnerships rather than owned assets. Precision Medicine Group said its market access consulting and drug commercialization support services are built to serve pharmaceutical manufacturers across the full clinical-to-commercial lifecycle, extending McKesson’s role beyond drug distribution into research...",
    "summary": "Blackstone has agreed to sell Precision Medicine Group to McKesson Corporation for approximately $2.25 billion.",
    "location": "Maryland, United States",
    "planning": true,
    "image_url": "https://news.media.outsourceaccelerator.com/wp-content/uploads/2026/09/mckesson-precision-medicine.jpg",
    "confidence": 0.9,
    "assets_tags": [
      "services"
    ],
    "published_at": "2026-09-09T10:00:00Z",
    "location_data": [
      {
        "state": "Maryland",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "TEXAS and MARYLAND, UNITED STATES - McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group from Blackstone for approximately $2.25 billion.",
    "amount_normalized": 2250000000,
    "related_company_name": "McKesson Corporation",
    "related_company_domain": "mckesson.com"
  }
}

curl https://signals.autobound.ai/v1/signals/a947df6d-0baa-2653-d4f4-bb7088c080ef \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"blackstone.com","limit":20}'